Equillium, Inc. (EQ)
2.21
-0.01
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
2.21
0.00 (0.00%)
After-Hours: 20:00
Equillium SG&A Expense (TTM) : 10.72M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.72M |
| March 31, 2026 | 10.46M |
| December 31, 2025 | 10.79M |
| September 30, 2025 | 10.14M |
| June 30, 2025 | 10.14M |
| March 31, 2025 | 11.14M |
| December 31, 2024 | 11.94M |
| September 30, 2024 | 13.39M |
| June 30, 2024 | 13.63M |
| March 31, 2024 | 13.59M |
| December 31, 2023 | 13.57M |
| September 30, 2023 | 15.53M |
| June 30, 2023 | 16.48M |
| March 31, 2023 | 17.44M |
| December 31, 2022 | 17.24M |
| September 30, 2022 | 14.88M |
| June 30, 2022 | 13.32M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.11M |
| December 31, 2021 | 11.41M |
| September 30, 2021 | 10.97M |
| June 30, 2021 | 10.37M |
| March 31, 2021 | 10.23M |
| December 31, 2020 | 10.16M |
| September 30, 2020 | 9.928M |
| June 30, 2020 | 9.772M |
| March 31, 2020 | 9.244M |
| December 31, 2019 | 9.087M |
| September 30, 2019 | 8.63M |
| June 30, 2019 | 7.492M |
| March 31, 2019 | 5.677M |
| December 31, 2018 | 3.121M |
| September 30, 2018 | 1.411M |
| March 31, 2018 | 0.4078M |
| September 30, 2017 | 0.0338M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Fortress Biotech, Inc. | 68.84M |
| Cue Biopharma, Inc. | 59.11M |
| Legend Biotech Corp. | 376.01M |
| Dianthus Therapeutics, Inc. | 44.15M |